clinical trial · NCT06678269
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Metastatic Breast CancerStage IV Breast CancerBreast CancerBreast Cancer Stage IVBreast Cancer MetastaticHER2-negative Breast CancerHER2 Negative Breast CarcinomaHormone-receptor-positive Breast CancerAbemaciclibRadiation Therapy
brief summary
The purpose of this study is to test different doses of abemaciclib to find the best dose in participants while receiving hormone therapy and radiation therapy.
started
Nov 15, 2024
primary completion
Nov 30, 2028
completion
Nov 30, 2028
last updated
Feb 12, 2026
official title
A Phase I Study of Concurrent Abemaciclib and Radiation Therapy (RT) for Patients With Metastatic Hormone Receptor Positive (HR+), HER2 Negative (HER2-) Breast Cancer
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol